ABCs Report: Methicillin-Resistant Staphylococcus aureus, 2008
Active Bacterial Core Surveillance (ABCs): Emerging Infections Program Network
Print-friendly version of this surveillance report [44 KB, 1 page]
ABCs Areas
California (3 county San Francisco Bay area); Colorado (5 county Denver area); Connecticut; Georgia (8 county Atlanta area); Maryland (1 county Baltimore area); Minnesota (2 metro Twin City counties); New York (1 Rochester county); Oregon (3 county Portland area); Tennessee (1 Nashville county). Note the population under surveillance changed from 2007 (bold).
ABCs Population
The surveillance areas represent 19,086,261 persons.
Source: National Center for Health Statistics bridged-race vintage 2008 postcensal file.
ABCs Case Definition
Invasive methicillin-resistant Staphylococcus aureus (MRSA) disease: isolation of MRSA from a normally sterile site in a resident of the surveillance area in 2008. Cases of disease are classified into one of three epidemiologic classifications. A case is classified as hospital-onset (HO) if the MRSA infection was identified more than 2 days after hospital admission; as healthcare-associated community-onset (HACO) if the MRSA infection was identified 2 or fewer days after admission and had one of more of the following: 1) a history of hospitalization, surgery, dialysis or residence in a long term care facility in the previous year, or 2) the presence of a central vascular catheter. If none of the previously mentioned criteria are met, a case is classified as community-associated (CA)†.
ABCs Methodology
ABCs personnel routinely contacted all microbiology laboratories serving acute care hospitals in their area to identify cases. Standardized case report forms that collect demographic characteristics, clinical syndrome, and outcome of illness were completed for each identified case. Selected isolates were collected and sent to CDC for routine testing including: antimicrobial susceptibility testing, toxin testing and SCCmec typing. Pulsed field gel electrophoresis (PFGE) was discontinued in 2008. An Inferred PFGE Algorithm based on molecular characteristics of an isolate has been validated for the use with isolates collected though this surveillance only (http://www.cdc.gov/HAI/settings/lab/inferred-PFGE-algorithm.html). Regular laboratory audits assessed completeness of active surveillance and detected additional cases.
Rates of invasive MRSA disease were calculated using population estimates for 2008. For national estimates of cases, race- and age-specific rates of disease were applied from the aggregate surveillance area to the age and racial distribution of the 2008 U.S. population. Cases with unknown race were distributed by site based on reported race distribution for known cases.
†Epidemiological Classification Definition Changes
Previous documented MRSA colonization or infection is not a determinant in classifying patients, unlike previously published estimates which include such patients in the HACO category. HO cases are now defined based on reported calendar dates (i.e. greater than "48 hours") this also differs from previously published estimates. (JAMA, 2007 Oct 17; 298 (15): 1765-71)
Reported ABCs Profiles
| Race | No. | (Rate*) |
|---|---|---|
| White | 3256 | (24.5) |
| Black | 2002 | (60.1) |
| Other | 222 | (13.2) |
Unknown race (n=771) distributed amongst known
* Cases per 100,000 population for ABCs areas
| MRSA Class | No. (Rate*) Cases^ |
No. (Rate*) Deaths˜ |
Inferred PFGE Type (N,%) Tot N± |
Inferred PFGE Type (N,%) USA100± |
Inferred PFGE Type (N,%) USA300± |
|---|---|---|---|---|---|
| HO | 1276 (6.7) | 304 (1.6) | 247 | 177 (71.7) | 48 (19.4) |
| HACO | 3203 (16.8) | 481 (2.5) | 585 | 363 (62.1) | 157 (26.8) |
| CA | 929 (4.9) | 91 (0.5) | 151 | 46 (30.5) | 103 (68.2) |
*Cases per 100,000 population for ABCs areas
^n=151 ˜n=20; could not be classified after chart review
±1351 isolates were eligible for testing up receipt to CDC, 1005 have
Inferred PFGE algorithm, 13 will require direct PFGE
| Syndrome | CA (n=929) |
HACO (n=3203) |
HO (n=1276) |
|---|---|---|---|
| Bloodstream Infection with other syndrome | 512 | 2143 | 862 |
| Bloodstream Infection with no other syndrome | 158 | 987 | 521 |
| Pneumonia | 155 | 459 | 232 |
| Osteomyelitis | 122 | 322 | 105 |
| Endocarditis | 94 | 195 | 45 |
| Cellulitis | 168 | 273 | 55 |
| Skin abscess* | 11 | 28 | 13 |
Note: Some cases had more than one syndrome.
*Category includes skin abscess, necrotizing fasciitis, gangrene, wounds
National Estimates of Invasive Disease
Cases: 89,785 (29.53/100,000)
Deaths: 15,249 (5.02/100,000)
Citation
Centers for Disease Control and Prevention. 2008. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Methicillin-Resistant Staphylococcus aureus, 2008.
Available via the Internet: http://www.cdc.gov/abcs/reports-findings/survreports/mrsa08.pdf
This symbol means you are leaving the CDC.gov Web site. For more information, please see CDC's Exit Notification and Disclaimer policy.
File Formats: All viewers, players, and plug-ins used on this site can be downloaded from the file formats page. (For example: Adobe Acrobat Reader for pdf files, Windows Media Player for audio and video files, PowerPoint Viewer for presentation slides, etc.)
Copyrighted images: Images on this website which are copyrighted were used with permission of the copyright holder and are not in the public domain. CDC has licensed these images for use in the materials provided on this website, and the materials in the form presented on this website may be used without seeking further permission. Any other use of copyrighted images requires permission from the copyright holder.
Contact Us:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348 - New Hours of Operation
8am-8pm ET/Monday-Friday
Closed Holidays - cdcinfo@cdc.gov


